- Investing Ideas
- /
- Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
68
Companies with a Value score of at least 3, ordered by Value score
68 companies
Genomma Lab Internacional. de
Market Cap: Mex$21.3b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
LAB B
Mex$22.13
7D
5.3%
1Y
18.9%
Merck
Market Cap: Mex$191.8b
Operates as a healthcare company worldwide.
MRK *
Mex$1,466.00
7D
-1.9%
1Y
-29.6%
Teva Pharmaceutical Industries
Market Cap: Mex$20.1b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA N
Mex$338.92
7D
4.3%
1Y
18.9%
Vaxart
Market Cap: Mex$117.4m
A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform.
VXRT *
Mex$12.00
7D
0%
1Y
n/a
CSPC Pharmaceutical Group
Market Cap: Mex$69.4b
An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the People’s Republic of China, other Asian regions, North America, Europe, and internationally.
1093 N
Mex$15.69
7D
0%
1Y
-27.0%
CureVac
Market Cap: Mex$727.3m
A biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA).
CVAC N
Mex$82.00
7D
0%
1Y
n/a
Exact Sciences
Market Cap: Mex$10.7b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS *
Mex$1,050.00
7D
0%
1Y
16.1%
Novartis
Market Cap: Mex$181.7b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NOVN N
Mex$2,207.59
7D
0%
1Y
n/a
Incyte
Market Cap: Mex$12.6b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY *
Mex$1,180.69
7D
0%
1Y
n/a
GSK
Market Cap: Mex$58.7b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSK1 N
Mex$356.95
7D
0%
1Y
n/a
Organon
Market Cap: Mex$2.4b
Develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle East, Russia, Africa, and internationally.
OGN *
Mex$150.00
7D
0%
1Y
-57.9%
Zai Lab
Market Cap: Mex$3.3b
A biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases.
ZLAB N
Mex$565.00
7D
0%
1Y
n/a
Regeneron Pharmaceuticals
Market Cap: Mex$62.5b
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
REGN *
Mex$11,620.03
7D
0%
1Y
-29.3%
Pfizer
Market Cap: Mex$133.3b
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.
PFE *
Mex$452.50
7D
0.6%
1Y
-6.7%
Johnson & Johnson
Market Cap: Mex$369.5b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ *
Mex$2,946.50
7D
-0.07%
1Y
18.3%
Perrigo
Market Cap: Mex$3.7b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO N
Mex$557.52
7D
0%
1Y
n/a
BeiGene
Market Cap: Mex$14.0b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
BGNE N
Mex$2,858.16
7D
0%
1Y
n/a
Jazz Pharmaceuticals
Market Cap: Mex$6.6b
Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.
JAZZ N
Mex$2,043.57
7D
0%
1Y
n/a
CRISPR Therapeutics
Market Cap: Mex$3.2b
A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
CRSP N
Mex$727.07
7D
0%
1Y
-20.5%
Viatris
Market Cap: Mex$10.1b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS *
Mex$179.00
7D
0%
1Y
2.9%
Halozyme Therapeutics
Market Cap: Mex$6.7b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.
HALO *
Mex$1,017.50
7D
0%
1Y
n/a
Ipsen
Market Cap: Mex$9.2b
Operates as a biopharmaceutical company worldwide.
IPN N
Mex$1,936.56
7D
0%
1Y
n/a
Elanco Animal Health
Market Cap: Mex$4.8b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN *
Mex$246.50
7D
0%
1Y
n/a
Royalty Pharma
Market Cap: Mex$18.3b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX N
Mex$630.00
7D
0%
1Y
40.5%
Gilead Sciences
Market Cap: Mex$138.2b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD *
Mex$2,080.00
7D
4.9%
1Y
84.2%
Astellas Pharma
Market Cap: Mex$2.8t
Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.
4503 N
Mex$204.11
7D
0%
1Y
n/a
ACADIA Pharmaceuticals
Market Cap: Mex$3.8b
A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.
ACAD *
Mex$509.00
7D
0%
1Y
60.5%
Ardelyx
Market Cap: Mex$1.1b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX *
Mex$105.50
7D
0%
1Y
-7.3%
Agilent Technologies
Market Cap: Mex$29.2b
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
A *
Mex$2,907.11
7D
0%
1Y
n/a
Biogen
Market Cap: Mex$18.7b
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.
BIIB *
Mex$2,445.00
7D
0%
1Y
-34.2%
BioMarin Pharmaceutical
Market Cap: Mex$11.1b
A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.
BMRN *
Mex$1,480.00
7D
0%
1Y
n/a
Novartis
Market Cap: Mex$181.7b
Engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally.
NVS N
Mex$2,092.19
7D
0%
1Y
n/a
Bayer
Market Cap: Mex$24.2b
Operates as a life science company worldwide.
BAYN N
Mex$509.86
7D
0%
1Y
n/a
Medpace Holdings
Market Cap: Mex$8.4b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP *
Mex$5,900.00
7D
0%
1Y
n/a
Amgen
Market Cap: Mex$152.5b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
AMGN *
Mex$5,429.50
7D
2.4%
1Y
4.7%
Bristol-Myers Squibb
Market Cap: Mex$97.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BMY *
Mex$875.00
7D
-5.9%
1Y
25.9%